MORANDI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.259
EU - Europa 2.616
AS - Asia 852
SA - Sud America 88
OC - Oceania 17
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.849
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.250
PL - Polonia 1.038
RU - Federazione Russa 662
IT - Italia 369
HK - Hong Kong 283
SG - Singapore 222
CN - Cina 189
IE - Irlanda 152
SE - Svezia 140
BR - Brasile 77
FR - Francia 49
DE - Germania 38
FI - Finlandia 38
IN - India 34
GB - Regno Unito 30
ES - Italia 29
VN - Vietnam 29
ID - Indonesia 26
NL - Olanda 23
JO - Giordania 22
AU - Australia 17
CH - Svizzera 12
BE - Belgio 11
CI - Costa d'Avorio 11
UA - Ucraina 11
TR - Turchia 8
KR - Corea 7
AE - Emirati Arabi Uniti 5
TW - Taiwan 5
BD - Bangladesh 4
CA - Canada 4
GR - Grecia 4
AZ - Azerbaigian 3
CL - Cile 3
EC - Ecuador 3
IL - Israele 3
IQ - Iraq 3
AR - Argentina 2
AT - Austria 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
MX - Messico 2
PT - Portogallo 2
BG - Bulgaria 1
CO - Colombia 1
EG - Egitto 1
EU - Europa 1
GL - Groenlandia 1
GT - Guatemala 1
JP - Giappone 1
KE - Kenya 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
QA - Qatar 1
SA - Arabia Saudita 1
TH - Thailandia 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 6.849
Salva come PNG Salva come JPEG
Città #
Warsaw 1.034
Santa Clara 832
Fairfield 453
Hong Kong 246
Ashburn 220
Woodbridge 198
Houston 186
Seattle 185
Cambridge 164
Dublin 152
Singapore 139
Chandler 134
Wilmington 127
Florence 120
Ann Arbor 90
Altamura 69
Lawrence 69
Beijing 67
Princeton 43
Medford 29
Paris 28
Dong Ket 27
Shanghai 27
Jakarta 26
San Diego 26
Moscow 24
Mumbai 22
Boston 19
Barcelona 18
Melbourne 17
Buffalo 14
Kent 14
Bern 12
Boardman 12
Falls Church 12
Hefei 12
Helsinki 12
Phoenix 12
Abidjan 11
Brussels 11
São Paulo 10
Jacksonville 9
Los Angeles 9
Munich 9
Yubileyny 9
Chieri 8
Bengaluru 7
London 7
Milan 7
Turin 7
Turku 7
Donostia / San Sebastian 6
Frankfurt am Main 6
Lappeenranta 6
Belo Horizonte 5
Brasília 5
Redmond 5
Andover 4
Canicattì 4
Dearborn 4
Kilburn 4
Naples 4
New York 4
Nuremberg 4
Qingdao 4
Redwood City 4
Ribeirão Preto 4
Rome 4
Stockholm 4
Baghdad 3
Baku 3
Brooklyn 3
Cagliari 3
Hillsboro 3
Impruneta 3
Newark 3
Norwalk 3
Prato 3
Pune 3
San Francisco 3
Santiago 3
Seodaemun-gu 3
Siena 3
St Louis 3
Wroclaw 3
Amman 2
Amsterdam 2
Ankara 2
Arezzo 2
Athens 2
Bologna 2
Campi Bisenzio 2
Carpaneto Piacentino 2
Dubai 2
Fiesole 2
Goiânia 2
Guangzhou 2
Hangzhou 2
Hanover 2
Istanbul 2
Totale 5.161
Salva come PNG Salva come JPEG
Nome #
The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines. 329
Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts. 293
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells. 290
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells. 278
Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells 250
Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer 244
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread 210
The metabolic gene HAO2 is downregulated in hepatocellular carcinoma and predicts metastasis and poor survival 194
Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer 178
Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib 169
Stromal-induced downregulation of miR-1247 promotes prostate cancer malignancy 168
Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts 167
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 163
Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival 157
Fat and Furious: Lipid Metabolism in Antitumoral Therapy Response and Resistance 152
Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer 150
Lactate modulates CD4 + T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis 149
Senescent stroma promotes prostate cancer progression: The role of miR-210 148
Signaling pathways regulating redox balance in cancer metabolism 147
miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors. 147
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells 145
Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors 142
Linking metabolic reprogramming to therapy resistance in cancer 135
ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion. 134
Lactate: A Metabolic Driver in the Tumour Landscape 130
Metabolic implication of tumor:stroma crosstalk in breast cancer. 125
Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation 118
GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors 109
Nutrient Exploitation within the Tumor–Stroma Metabolic Crosstalk 107
Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism 102
Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependence 97
Lactate rewires lipid metabolism and sustains a metabolic-epigenetic axis in prostate cancer 96
Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytes 94
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 93
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside 90
Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer 87
RET in breast cancer: functional and therapeutic implications 87
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming 87
Targeting RET-interleukin-6 crosstalk to impair metastatic dissemination in breast cancer 83
A novel phage display based platform for exosome diversity characterization 82
FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer 81
Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase 79
Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance 78
Lactate supports cell-autonomous ECM production to sustain metastatic behavior in prostate cancer 75
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations 75
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma 74
Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO) 70
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: a systematic review and meta-analysis 68
Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer 68
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers 66
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis 62
Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease 25
Cardioprotection in patients with anthracycline-treated breast cancer: final analysis from the 2 × 2 randomized, placebo-controlled, double-blind SAFE trial 5
CD44 and SLC1A2 are commonly regulated but do not form a fusion transcript in ER+ breast cancer 4
Totale 6.956
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.401
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.401
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202028 0 0 0 0 0 0 0 0 0 0 0 28
2020/2021804 58 79 25 104 44 69 49 48 85 147 48 48
2021/2022396 13 69 36 14 20 11 20 42 11 32 40 88
2022/2023778 62 190 44 41 49 137 96 35 69 9 27 19
2023/2024402 16 35 49 15 31 23 20 102 28 22 31 30
2024/20252.566 84 234 153 383 695 365 64 191 111 76 100 110
Totale 6.956